vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and INSTEEL INDUSTRIES INC (IIIN). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $159.9M, roughly 1.8× INSTEEL INDUSTRIES INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 4.7%, a 91.6% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 12.0%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.
ACAD vs IIIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $159.9M |
| Net Profit | $273.6M | $7.6M |
| Gross Margin | 90.8% | 11.3% |
| Operating Margin | 6.1% | 6.0% |
| Net Margin | 96.3% | 4.7% |
| Revenue YoY | 9.4% | 23.3% |
| Net Profit YoY | 90.3% | 602.4% |
| EPS (diluted) | $1.61 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $159.9M | ||
| Q3 25 | $278.6M | $177.4M | ||
| Q2 25 | $264.6M | $179.9M | ||
| Q1 25 | $244.3M | $160.7M | ||
| Q4 24 | $259.6M | $129.7M | ||
| Q3 24 | $250.4M | $134.3M | ||
| Q2 24 | $242.0M | $145.8M | ||
| Q1 24 | $205.8M | $127.4M |
| Q4 25 | $273.6M | $7.6M | ||
| Q3 25 | $71.8M | $14.6M | ||
| Q2 25 | $26.7M | $15.2M | ||
| Q1 25 | $19.0M | $10.2M | ||
| Q4 24 | $143.7M | $1.1M | ||
| Q3 24 | $32.8M | $4.7M | ||
| Q2 24 | $33.4M | $6.6M | ||
| Q1 24 | $16.6M | $6.9M |
| Q4 25 | 90.8% | 11.3% | ||
| Q3 25 | 92.2% | 16.1% | ||
| Q2 25 | 92.2% | 17.1% | ||
| Q1 25 | 91.7% | 15.3% | ||
| Q4 24 | 91.6% | 7.3% | ||
| Q3 24 | 92.5% | 9.1% | ||
| Q2 24 | 92.5% | 10.6% | ||
| Q1 24 | 88.8% | 12.3% |
| Q4 25 | 6.1% | 6.0% | ||
| Q3 25 | 12.8% | 10.8% | ||
| Q2 25 | 12.2% | 11.0% | ||
| Q1 25 | 7.9% | 8.3% | ||
| Q4 24 | 59.1% | 1.1% | ||
| Q3 24 | 12.6% | 4.5% | ||
| Q2 24 | 12.6% | 6.0% | ||
| Q1 24 | 7.4% | 7.0% |
| Q4 25 | 96.3% | 4.7% | ||
| Q3 25 | 25.8% | 8.2% | ||
| Q2 25 | 10.1% | 8.4% | ||
| Q1 25 | 7.8% | 6.4% | ||
| Q4 24 | 55.4% | 0.8% | ||
| Q3 24 | 13.1% | 3.5% | ||
| Q2 24 | 13.8% | 4.5% | ||
| Q1 24 | 8.0% | 5.4% |
| Q4 25 | $1.61 | $0.39 | ||
| Q3 25 | $0.42 | $0.74 | ||
| Q2 25 | $0.16 | $0.78 | ||
| Q1 25 | $0.11 | $0.52 | ||
| Q4 24 | $0.86 | $0.06 | ||
| Q3 24 | $0.20 | $0.24 | ||
| Q2 24 | $0.20 | $0.34 | ||
| Q1 24 | $0.10 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $15.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $358.8M |
| Total Assets | $1.6B | $456.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $15.6M | ||
| Q3 25 | $258.0M | $38.6M | ||
| Q2 25 | $253.6M | $53.7M | ||
| Q1 25 | $217.7M | $28.4M | ||
| Q4 24 | $319.6M | $36.0M | ||
| Q3 24 | $155.1M | $111.5M | ||
| Q2 24 | $177.1M | $97.7M | ||
| Q1 24 | $204.7M | $83.9M |
| Q4 25 | $1.2B | $358.8M | ||
| Q3 25 | $917.3M | $371.5M | ||
| Q2 25 | $822.4M | $356.2M | ||
| Q1 25 | $765.2M | $341.4M | ||
| Q4 24 | $732.8M | $331.6M | ||
| Q3 24 | $577.2M | $350.9M | ||
| Q2 24 | $516.7M | $346.0M | ||
| Q1 24 | $464.0M | $340.6M |
| Q4 25 | $1.6B | $456.1M | ||
| Q3 25 | $1.3B | $462.6M | ||
| Q2 25 | $1.2B | $471.9M | ||
| Q1 25 | $1.1B | $421.9M | ||
| Q4 24 | $1.2B | $404.7M | ||
| Q3 24 | $976.9M | $422.6M | ||
| Q2 24 | $914.1M | $414.6M | ||
| Q1 24 | $855.1M | $397.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $-701.0K |
| Free Cash FlowOCF − Capex | — | $-2.2M |
| FCF MarginFCF / Revenue | — | -1.4% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | -0.18× | -0.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $439.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $-701.0K | ||
| Q3 25 | $74.3M | $-17.0M | ||
| Q2 25 | $64.0M | $28.5M | ||
| Q1 25 | $20.3M | $-3.3M | ||
| Q4 24 | $40.4M | $19.0M | ||
| Q3 24 | $63.2M | $16.2M | ||
| Q2 24 | $25.0M | $18.8M | ||
| Q1 24 | $29.1M | $1.4M |
| Q4 25 | — | $-2.2M | ||
| Q3 25 | $73.9M | $-18.7M | ||
| Q2 25 | — | $26.9M | ||
| Q1 25 | — | $-5.5M | ||
| Q4 24 | — | $16.3M | ||
| Q3 24 | $63.2M | $14.5M | ||
| Q2 24 | — | $15.5M | ||
| Q1 24 | — | $-580.0K |
| Q4 25 | — | -1.4% | ||
| Q3 25 | 26.5% | -10.6% | ||
| Q2 25 | — | 15.0% | ||
| Q1 25 | — | -3.5% | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | 25.2% | 10.8% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | -0.5% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | 0.1% | 1.0% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.5% |
| Q4 25 | -0.18× | -0.09× | ||
| Q3 25 | 1.03× | -1.17× | ||
| Q2 25 | 2.40× | 1.88× | ||
| Q1 25 | 1.07× | -0.32× | ||
| Q4 24 | 0.28× | 17.56× | ||
| Q3 24 | 1.93× | 3.48× | ||
| Q2 24 | 0.75× | 2.86× | ||
| Q1 24 | 1.76× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
IIIN
| Welded Wire Reinforcement | $108.4M | 68% |
| PC Strand | $51.6M | 32% |
